We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
-7.2%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.45B
AUM Growth
-$150M
Cap. Flow
-$19.9M
Cap. Flow %
-1.37%
Top 10 Hldgs %
43.28%
Holding
59
New
1
Increased
1
Reduced
53
Closed
–

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$16.4M
2
PFE icon
Pfizer
PFE
+$16M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$15.2M
2
COF icon
Capital One
COF
+$13.4M
3
INTC icon
Intel
INTC
+$8.54M
4
CVX icon
Chevron
CVX
+$1.21M
5
XOM icon
ExxonMobil
XOM
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 27.61%
2 Financials 17.58%
3 Industrials 10.97%
4 Consumer Staples 10.3%
5 Energy 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$134B
$78.7M 5.44%
824,975
-9,090
-1% -$900K
MRK icon
2
Merck
MRK
$321B
$76.1M 5.26%
883,465
-6,650
-0.7% -$594K
GD icon
3
General Dynamics
GD
$103B
$68.1M 4.71%
321,109
-2,500
-0.8% -$565K
MET icon
4
MetLife
MET
$62.5B
$64.1M 4.43%
1,054,486
-237,695
-18% -$15.2M
KO icon
5
Coca-Cola
KO
$381B
$63.9M 4.42%
1,141,047
-13,280
-1% -$825K
CVX icon
6
Chevron
CVX
$383B
$61.4M 4.24%
427,417
-7,950
-2% -$1.21M
VZ icon
7
Verizon
VZ
$193B
$60.9M 4.21%
1,603,271
-18,365
-1% -$818K
XOM icon
8
ExxonMobil
XOM
$651B
$52.6M 3.63%
602,292
-11,195
-2% -$1.02M
WBA
9
DELISTED
Walgreens Boots Alliance
WBA
$50.9M 3.52%
1,621,465
-15,095
-0.9% -$559K
AMGN icon
10
Amgen
AMGN
$209B
$49.4M 3.41%
219,130
-2,335
-1% -$566K
PFE icon
11
Pfizer
PFE
$142B
$47.3M 3.27%
1,081,895
+330,040
+44% +$16M
IBM icon
12
IBM
IBM
$209B
$43.8M 3.03%
369,022
-4,010
-1% -$526K
DOW icon
13
Dow Inc
DOW
$21.7B
$38.2M 2.64%
868,970
-9,565
-1% -$485K
INTC icon
14
Intel
INTC
$460B
$35.1M 2.42%
1,360,448
-250,520
-16% -$8.54M
SO icon
15
Southern Company
SO
$109B
$34.2M 2.36%
502,800
-5,745
-1% -$435K
COF icon
16
Capital One
COF
$129B
$32.2M 2.22%
349,045
-126,090
-27% -$13.4M
EXC icon
17
Exelon
EXC
$46.6B
$31.4M 2.17%
837,151
-9,735
-1% -$430K
MS icon
18
Morgan Stanley
MS
$330B
$30.8M 2.13%
390,100
-4,330
-1% -$365K
MMM icon
19
3M
MMM
$90.8B
$30.7M 2.12%
332,189
-3,606
-1% -$396K
JNJ icon
20
Johnson & Johnson
JNJ
$617B
$27.7M 1.91%
169,525
-950
-0.6% -$161K
KHC icon
21
Kraft Heinz
KHC
$31.3B
$26.8M 1.85%
803,275
-8,750
-1% -$325K
AIG icon
22
American International
AIG
$41.8B
$23.9M 1.65%
503,990
-5,490
-1% -$288K
CEG icon
23
Constellation Energy
CEG
$94.1B
$22.1M 1.53%
265,790
-5,420
-2% -$400K
GS icon
24
Goldman Sachs
GS
$302B
$22M 1.52%
75,208
-905
-1% -$293K
UNH icon
25
UnitedHealth
UNH
$383B
$19.7M 1.36%
38,933
-260
-0.7% -$137K
1
2 3

Similar funds

FCP
Fidelis Capital Partners Tampa, Florida $1.4B AUM 31.16% 1-Year Est. Return
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
IAS
Insigneo Advisory Services Miami, Florida $1.41B AUM 27.46% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
SP
Steelhead Partners Seattle, Washington $1.39B AUM 0.01% 1-Year Est. Return

Edgar Lomax Company's Q3 2022 Portfolio in Review

As of Q3 2022, Edgar Lomax Company held 59 positions worth $1.45B, down 9.4% from $1.6B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 1.7%. Edgar Lomax Company opened 1 new position and made no exits, leaving the 59-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • Edgar Lomax Company's largest Q3 2022 buy was Procter & Gamble: 115,510 shares worth $14.6M.
  • Edgar Lomax Company added most to Pfizer in Q3 2022, an estimated $16M increase.
  • Edgar Lomax Company's biggest Q3 2022 reduction was MetLife, cutting an estimated $15.2M.
  • Edgar Lomax Company's ten largest holdings make up 43% of its $1.45B portfolio in Q3 2022.
  • Edgar Lomax Company opened 1 new position and closed 0 in Q3 2022.
  • Edgar Lomax Company's portfolio value fell 9.4% quarter-over-quarter to $1.45B.

Based on Edgar Lomax Company's 13F filing for Q3 2022, filed 14 Nov 2022.